AI eye check in your Doctor's office could save your sight

NCT ID NCT06763952

Not yet recruiting Diagnosis Sponsor: University of Wisconsin, Madison Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using an AI program to screen for diabetic eye disease during regular primary care visits can get more people to follow up with an eye specialist. It will include 4,000 adults with diabetes who have Medicaid and haven't had an eye exam in the past year. The goal is to see if this approach improves screening rates and reduces racial and ethnic gaps in eye care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-based eye screening program
What this could lead to: If successful, this could make diabetic eye screening more accessible and reduce vision loss, especially among minority groups.
What could go wrong: This is an early-stage trial with no results yet. The AI screening may not improve follow-up rates as hoped, and real-world adoption could face barriers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus diabetic retinopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS DIABETIC RETINOPATHY

Contacts and locations

Locations

UW School of Medicine and Public Health

Madison, Wisconsin, 53792, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.